Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
7.25T | 9.19T | 8.51T | 6.33T | 6.83T | Gross Profit |
1.07T | 1.05T | 895.33B | 675.42B | 696.81B | EBIT |
327.26B | 384.21B | 300.16B | 162.34B | -48.72B | EBITDA |
453.99B | 578.30B | 457.11B | 307.84B | 48.72B | Net Income Common Stockholders |
471.41B | 543.00B | 424.32B | 223.26B | -197.45B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
506.27B | 999.45B | 1.37T | 1.09T | 838.59B | Total Assets |
8.92T | 7.95T | 8.26T | 6.94T | 6.32T | Total Debt |
2.68T | 2.09T | 2.44T | 2.43T | 2.38T | Net Debt |
2.17T | 1.48T | 1.86T | 1.69T | 1.86T | Total Liabilities |
5.36T | 4.97T | 5.92T | 5.03T | 4.72T | Stockholders Equity |
3.46T | 2.88T | 2.24T | 1.82T | 1.52T |
Cash Flow | Free Cash Flow | |||
289.10B | 502.07B | 210.11B | 272.98B | 217.10B | Operating Cash Flow |
442.47B | 606.33B | 311.92B | 397.07B | 326.98B | Investing Cash Flow |
-334.43B | 156.81B | -79.66B | -116.26B | -209.79B | Financing Cash Flow |
-254.17B | -766.59B | -419.64B | -68.50B | -93.26B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | $9.79T | 17.88 | 29.69% | 2.64% | 32.83% | 50.73% | |
79 Outperform | $10.25T | 11.14 | 10.17% | 3.56% | -4.85% | 2.91% | |
79 Outperform | $7.94T | 9.07 | 11.74% | 3.23% | 10.04% | -13.12% | |
77 Outperform | $4.25T | 8.38 | 13.98% | 3.51% | 7.44% | 8.27% | |
73 Outperform | $4.24T | 7.55 | 12.19% | 3.50% | 5.52% | 46.82% | |
72 Outperform | $10.13T | 11.44 | 15.55% | 2.68% | 4.95% | 11.34% | |
61 Neutral | $704.84M | 7.18 | 6.37% | 3.67% | 1.48% | -24.42% |